CNPq Research Productivity Fellow (Level PQ-2). He has a degree in Genetics from Universidad Nacional Misiones (Argentina – 2004) and a master’s degree in Genetics and Molecular Biology from Universidade Federal do Rio Grande do Sul (Brazil – 2006). After […]
Paulo Lee Ho possui pós-doutorado na Universidade de Columbia (EUA) e doutorado em Ciências Biológicas (Bioquímica) pela Universidade de São Paulo (USP). Possui anos de contribuições técnicas e científicas nas áreas de desenvolvimento de vacinas, biotecnologia, genômica, toxinologia e biologia […]
Artur Roberto Couto has a master’s degree in Economics from Cândido Mendes University, an executive MBA from Coppead/UFRJ and a postgraduate degree in Public Administration from FGV. With more than 35 years of experience in public health management, he was […]
Gustavo Mendes has a PhD in Pharmaceutical Sciences from the State University of Maringá, a master’s degree in Toxicology Applied to Health Surveillance from the State University of Londrina and a specialist in Health Surveillance from the Oswaldo Cruz Foundation […]
Patrícia Neves has a PhD in Cellular and Molecular Biology and a master’s degree in Parasite Biology from the Oswaldo Cruz Foundation (Fiocruz), and a degree in Biomedicine from the Federal University of the State of Rio de Janeiro (UERJ). […]
Maria Augusta Arruda has a PhD in Pharmacology and has almost 30 years of experience in research environments. She was a researcher at the Oswaldo Cruz Foundation (Fiocruz), professor at the State University of Rio de Janeiro (UERJ) and led […]
Fernando Lobos is an engineer with 25 years of management experience in pharmaceutical companies, focusing on business development, strategic planning, international business, public relations and international law. He was a board member of the Network of Vaccine Manufacturers in Developing […]
Dr. Ralf Clemens, MD, PhD serves as Senior Vice President at GRID Rio (Global Research in Infectious Diseases) and advisor to the Bill & Melinda Gates Foundation. Dr. Clemens served as a Senior Vice President and Head of Development for […]
Andrew holds the position of General Manager at Shanghai Wotai Biotechnology, a Walvax subsidiary, and is the Director of Business Development at Walvax Biotechnology Ltd. He sustains more than 30 years of intercultural experience on molecular cancer drug, antibody therapeutics, […]
